Potential cancer-fighting Ocimum gratissimum (OG) leaf extracts: increased anti-proliferation activity of partially purified fractions and their spectral fingerprints.
BACKGROUND
Cancer causes about 13% of all deaths. According to the American Cancer Society, world-wide cancer deaths were 7.6 million in 2007. African Americans and other minorities are disproportionately affected. Effective cancer chemotherapy is scarce. This study is part of an ongoing search for potential cancer-fighting agents in medicinal herbs. In previous in-vitro studies, we have shown that the aqueous extracts of the medicinal herb Ocimum gratissimum (Og) inhibit the proliferation of several cancer cell lines, especially prostate adenocarcinoma (PC-3) cells. Therefore, Og leaf extracts may harbor novel cancer-fighting compounds that need to be isolated, purified and characterized.


METHODS
Partially purified Og fractions were obtained from sequential extraction of Og powder with organic solvents of different polarities. The hypothesis that the anti-proliferation activity of the fractions will be significantly greater than that of either aqueous or ethanol extracts was tested by treating PC-3 cells with 1.61 mg/mL of each fraction. Spectral analysis of the fractions was also conducted.


RESULTS
Activity of the fractions was P2>P(3-2)>P(4-2)>P(3-1)>P(4-1). Fractions P2, P(3-2) and P(4-2) were 725, 75 and 2.3 times more active than the aqueous extract, respectively. Spectral analysis revealed peaks for: P(3-2) and aqueous extract at 208 nm, P2 and P(4-2) at 210 nm, and P(3-1) at 220 nm.


CONCLUSIONS
These findings suggest that fractions P2, P(3-2) and P(4-2) could be potential sources of Og's bioactive component(s) that warrant further purification and characterization.
Department of Biology, Jackson State University, 1400 JR Lynch Street, P.O. Box 18540, Jackson, MS 39217, USA. stephen.i.ekunwe@jsums.edu
Stephen I N
SI
Ekunwe
Melvanique S
MS
Thomas
Xuan
X
Luo
Hengshan
H
Wang
Yong
Y
Chen
Xiaopu
X
Zhang
Gregorio B
GB
Begonia
D000230:Adenocarcinoma / Q000628:therapy*; D049109:Cell Proliferation; D005591:Chemical Fractionation; D006801:Humans; D008297:Male; D031339:Ocimum / Q000737:chemistry; D010789:Phototherapy; D010936:Plant Extracts / Q000737:chemistry; D018515:Plant Leaves / Q000737:chemistry; D011471:Prostatic Neoplasms / Q000628:therapy*; D013056:Spectrophotometry, Ultraviolet; D013057:Spectrum Analysis
D010936:Plant Extracts